Cancer (journal)

From WikiMD's WELLNESSPEDIA




Cancer is a peer-reviewed scientific journal that focuses on the field of oncology. It is published by Wiley-Blackwell on behalf of the American Cancer Society. The journal was established in 1948 and has since become a leading source of information for researchers and clinicians in the field of cancer research and treatment.

Scope and Content[edit]

The journal covers a wide range of topics within oncology, including but not limited to:

The journal publishes original research articles, reviews, and editorials that contribute to the understanding and advancement of cancer research. It aims to provide comprehensive coverage of all aspects of cancer, from basic research to clinical applications.

Publication Frequency[edit]

Cancer is published biweekly, providing timely updates and new findings in the field of oncology. This frequent publication schedule allows for the rapid dissemination of important research findings to the scientific community and healthcare professionals.

Editorial Process[edit]

The journal employs a rigorous peer-review process to ensure the quality and validity of the research it publishes. Manuscripts submitted to Cancer are evaluated by experts in the field, who assess the scientific merit, originality, and relevance of the work. The editorial board is composed of leading oncologists and researchers who guide the journal's content and direction.

Impact and Influence[edit]

Cancer has a significant impact on the field of oncology, as evidenced by its impact factor of 6.860 as of 2022. The journal is widely read by oncologists, researchers, and healthcare professionals, and its articles are frequently cited in the scientific literature. Cancer is considered a valuable resource for those involved in cancer research and treatment.

Open Access and Availability[edit]

Cancer offers a hybrid open access model, allowing authors to choose to make their articles freely available to the public. This model supports the dissemination of research findings to a broader audience, including patients, caregivers, and policymakers.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.